Works about CELECOXIB
Results: 1283
Efficacy and Safety of Celecoxib and a Korean SYSADOA (JOINS) for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1036, doi. 10.3390/jcm14041036
- By:
- Publication type:
- Article
EDITORIAL.
- Published in:
- 2024
- Publication type:
- Editorial
Multistep Continuous Flow Synthesis of Isolable NH<sub>2</sub>‐Sulfinamidines via Nucleophilic Addition to Transient Sulfurdiimide.
- Published in:
- Chemistry - A European Journal, 2022, v. 28, n. 59, p. 1, doi. 10.1002/chem.202202066
- By:
- Publication type:
- Article
Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 3, p. 216, doi. 10.1002/hup.2401
- By:
- Publication type:
- Article
Imrecoxib and celecoxib affect sacroiliac joint inflammation in axSpA by regulating bone metabolism and angiogenesis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 6, p. 1585, doi. 10.1007/s10067-023-06541-8
- By:
- Publication type:
- Article
Efficacy of celecoxib as preemptive analgesia for patients undergoing laparoscopic inguinal hernia repair: a randomized trial.
- Published in:
- Surgery Today, 2021, v. 51, n. 7, p. 1118, doi. 10.1007/s00595-020-02199-w
- By:
- Publication type:
- Article
Postoperative analgesia using fentanyl plus celecoxib versus epidural anesthesia after laparoscopic colon resection.
- Published in:
- Surgery Today, 2017, v. 47, n. 2, p. 174, doi. 10.1007/s00595-016-1356-y
- By:
- Publication type:
- Article
Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature.
- Published in:
- Archives of Dermatological Research, 2007, v. 299, n. 4, p. 169, doi. 10.1007/s00403-007-0757-6
- By:
- Publication type:
- Article
Preparation and In Vitro/Vivo Evaluation of New Celecoxib Solid Dispersions with Co-Carrier Containing Aerosil and Poloxamer 188.
- Published in:
- Pharmaceutical Chemistry Journal, 2021, v. 54, n. 10, p. 1033, doi. 10.1007/s11094-021-02316-0
- By:
- Publication type:
- Article
Effect of celecoxib vs placebo as adjuvant therapy on disease-free survival among patients with breast cancer.
- Published in:
- Breast Cancer Research Review, 2021, n. 35, p. 4
- By:
- Publication type:
- Article
Celecoxib Nanoemulsion for Transdermal Drug Delivery: Characterization and In Vitro Evaluation.
- Published in:
- Journal of Dispersion Science & Technology, 2009, v. 30, n. 6, p. 834, doi. 10.1080/01932690802644012
- By:
- Publication type:
- Article
Crystallization of Celecoxib in Microemulsion Media.
- Published in:
- Journal of Dispersion Science & Technology, 2007, v. 28, n. 8, p. 1228, doi. 10.1080/01932690701528035
- By:
- Publication type:
- Article
Improvement of solubility of celecoxib by inclusion in MCM-41 mesoporous silica: drug loading and release.
- Published in:
- Turkish Journal of Chemistry, 2015, v. 39, n. 2, p. 317, doi. 10.3906/kim-1409-56
- By:
- Publication type:
- Article
Celecoxib treatment alleviates cerebral injury in a rat model of post-traumatic epilepsy.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.16555
- By:
- Publication type:
- Article
Chemoprevention, Risk Reduction, Therapeutic Prevention, or Preventive Therapy?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1815, doi. 10.1093/jnci/djq466
- By:
- Publication type:
- Article
Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1835, doi. 10.1093/jnci/djq442
- By:
- Publication type:
- Article
Celecoxib May Be Effective in Preventing Nonmelanoma Skin Cancers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. NP, doi. 10.1093/jnci/djq523
- Publication type:
- Article
Drugs To Prevent Colon Cancer Show Promise, But Hurdles Remain for Chemoprevention.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 11, p. 764, doi. 10.1093/jnci/djn187
- By:
- Publication type:
- Article
Electronic Health Records Help Recruit Trial Participants and Track Drug Safety.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 6, p. 384, doi. 10.1093/jnci/djn070
- By:
- Publication type:
- Article
Secondary Chemoprevention of Barrett's Esophagus With Cellecoxib: Results of a Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 7, p. 545, doi. 10.1093/jnci/djk112
- By:
- Publication type:
- Article
Celecoxib Shown Effective in Preventing Colon Polyps.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 10, p. 665, doi. 10.1093/jnci/djj220
- By:
- Publication type:
- Article
Researchers Plan To Continue To Study COX-2 Inhibitors in Cancer Treatment and Prevention.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 8, p. 552, doi. 10.1093/jnci/97.8.552
- By:
- Publication type:
- Article
FDA Issues Advice on COX-2 Inhibitors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 3, p. 171
- By:
- Publication type:
- Article
Prevention Study Halted Amid Concerns About Celebrex.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 2, p. 91
- Publication type:
- Article
Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 23, p. 1769, doi. 10.1093/jnci/djh322
- By:
- Publication type:
- Article
Death Receptor Regulation and Celecoxib-Induced Apoptosis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 23, p. 1727
- Publication type:
- Article
New Chromone-Thiazolopyrimidine Hybrids as Potent TNF-α, IL-6 and PGE2 Inhibitors: Synthesis, Anti-Inflammatory Evaluation and Molecular Modeling Studies.
- Published in:
- Polycyclic Aromatic Compounds, 2024, v. 44, n. 10, p. 6564, doi. 10.1080/10406638.2023.2278668
- By:
- Publication type:
- Article
Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2024, v. 39, n. 1, p. 1, doi. 10.1080/14756366.2024.2309171
- By:
- Publication type:
- Article
New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAF<sup>V600E</sup> and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2290461
- By:
- Publication type:
- Article
New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2281262
- By:
- Publication type:
- Article
Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2022.2162511
- By:
- Publication type:
- Article
Towards safer anti-inflammatory therapy: synthesis of new thymol–pyrazole hybrids as dual COX-2/5-LOX inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 294, doi. 10.1080/14756366.2022.2147164
- By:
- Publication type:
- Article
Rational design of biodegradable sulphonamide candidates treating septicaemia by synergistic dual inhibition of COX-2/PGE2 axis and DHPS enzyme.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 1737, doi. 10.1080/14756366.2022.2086868
- By:
- Publication type:
- Article
Challenging inflammatory process at molecular, cellular and in vivo levels via some new pyrazolyl thiazolones.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 669, doi. 10.1080/14756366.2021.1887169
- By:
- Publication type:
- Article
Synthesis and anti-inflammatory activity of celecoxib like compounds.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2013, v. 28, n. 5, p. 1105, doi. 10.3109/14756366.2012.710847
- By:
- Publication type:
- Article
Comparison of the adverse renal effects of different types of NSAID based on COX inhibition in patients with headaches.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2020, v. 66, n. 1, p. 3, doi. 10.33320/maced.pharm.bull.2020.66.01.006
- By:
- Publication type:
- Article
腰痹通胶囊联合塞来昔布胶囊治疗椎间盘源性腰痛的疗效 及对血清炎性因子和疼痛介质的影响.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 13, p. 2450, doi. 10.13241/j.cnki.pmb.2023.13.010
- By:
- Publication type:
- Article
EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2014, v. 17, n. 1, p. 10, doi. 10.1038/pcan.2013.53
- By:
- Publication type:
- Article
British Prostate Group BAUS Section of Oncology British Uro-Oncology Group.
- Published in:
- 2006
- Publication type:
- Abstract
Abstracts S29-S39.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2003, v. 6, p. S29, doi. 10.1038/sj.pcan.4500690
- Publication type:
- Article
Long-Term Efficacy and Safety of Celecoxib in Alzheimer’s Disease.
- Published in:
- Dementia & Geriatric Cognitive Disorders, 2006, v. 23, n. 1, p. 8, doi. 10.1159/000096588
- By:
- Publication type:
- Article
Celecoxib-loaded Nanoemulsion: Solubility of Celecoxib in Various Fractionated Medium Chain Triglycerides and Surfactants.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2023, v. 19, p. 30
- By:
- Publication type:
- Article
Inhibition of 12-LOX and COX-2 reduces the proliferation of human epidermoid carcinoma cells (A431) by modulating the ERK and PI3K-Akt signalling pathways.
- Published in:
- Experimental Dermatology, 2009, v. 18, n. 11, p. 939, doi. 10.1111/j.1600-0625.2009.00874.x
- By:
- Publication type:
- Article
Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib.
- Published in:
- Contact Dermatitis (01051873), 2012, v. 66, n. 2, p. 107, doi. 10.1111/j.1600-0536.2011.01982.x
- By:
- Publication type:
- Article
Cutaneous reaction to oral celecoxib with positive patch test.
- Published in:
- 2004
- By:
- Publication type:
- Case Study
Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation.
- Published in:
- Contact Dermatitis (01051873), 2002, v. 47, n. 2, p. 100, doi. 10.1034/j.1600-0536.2002.470208.x
- By:
- Publication type:
- Article
Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 7, p. 1049, doi. 10.3390/biom11071049
- By:
- Publication type:
- Article
VP52.29: Using celecoxib for the suppression of preterm labour instead of magnesium sulfate.
- Published in:
- Ultrasound in Obstetrics & Gynecology, 2020, v. 56, p. 303, doi. 10.1002/uog.23246
- By:
- Publication type:
- Article
Pain management strategies in adults with haemophilia: a retrospective study.
- Published in:
- Haemophilia, 2015, v. 21, n. 6, p. e487, doi. 10.1111/hae.12753
- By:
- Publication type:
- Article
Efficacy of celecoxib in the treatment of joint pain caused by advanced haemophilic arthropathy in adult patients with haemophilia A.
- Published in:
- Haemophilia, 2014, v. 20, n. 3, p. e225, doi. 10.1111/hae.12393
- By:
- Publication type:
- Article